	Sleep Disturbance, Treatment-Related Adverse Events, and Psychological Distress in Breast Cancer Patients: A Prospective Cohort Study. Patient Prefer Adherence Zhao F, Li Y, Zhou Y, Fu E, Zhu S, Yu L, Xu H, Li Q, Li Q, Zhang P, Wang J, Mo H. PMID: 42333247 [PubMed - in process]
	Development and Validation of a Multi-Omics Model Integrating US-Derived and WSI-Based Features to Predict Lymph Node Metastasis in Ovarian Cancer: A Multi-Center Retrospective Study. Int J Womens Health Yan G, Wu X, Zhao P, Zhou F, Xu S, Yao M, Ji Y, Li J, Feng Q, Zhao L, Du H. PMID: 42333220 [PubMed - in process]
	Single-cell RNA sequencing in ovarian cancer: decoding the tumor microenvironment for personalized therapy. J Ovarian Res Sayed U, Al-Hasnaawei S, Mohaisen-Mousa H, Jyothi-S R, Priyadarshini-Nayak P, Janney-J B, Singh G, Singh-Chauhan A, Kumar-Mishra M. PMID: 42332817 [PubMed - as supplied by publisher]
	Sodium-glucose cotransporter 2 inhibitors in breast cancer patients on endocrine therapy: a targeted strategy to mitigate long-term cardiometabolic risk. J Transl Med Quagliariello V, Berretta M, Bisceglia I, Barbato M, Arianna R, Forte P, Santagata J, Maurea C, Canale ML, Paccone A, Inno A, D'Ambrosio C, Oliva S, Dessalvi CC, Di Matola T, Gabrielli D, Maurea N. PMID: 42332771 [PubMed - as supplied by publisher]
	Decoding triple negative breast cancer bone metastasis: from 3D bioprinted models to clinical translation. J Nanobiotechnology Xu J, Kang Y, Song K, Fan J, Liu Y. PMID: 42332744 [PubMed - as supplied by publisher]
	Disease burden, machine learningâ€‘based risk factor identification in uterine cancer: A crossâ€‘sectional and bibliometric analysis. Medicine (Baltimore) Li Y, Wang H, Dong J, Wang S, Chen Z, Wang H. PMID: 42332450 [PubMed - in process]
	Assessment of breast cancer and feasibility of subtyping of breast cancer using thoracoabdominal staging photon-counting detector computed tomography. Sci Rep Neubauer C, Weiß JB, Fuentes MFM, Gebler O, Jung L, Huwer SI, Taran FA, Juhasz-Böss I, Bamberg F, Windfuhr-Blum M, Neubauer J. PMID: 42332073 [PubMed - in process]
	Nucleic sexual hormone receptor signaling pathways in breast cancer: function regulation, crosstalk, and therapeutic implications. NPJ Precis Oncol Zeng K, Wang A, Sun H, Wang C, Wang S, Zou R, Yang D, Bai Y, Wang M, Xu Y, Zhao Y. PMID: 42332013 [PubMed - as supplied by publisher]
	Prognostic analysis of epithelial ovarian cancer patients with normal CA125 level: a population-based comparative study. Sci Rep Liu C, Zhang L, Huang Y, Shi H, Yang Z. PMID: 42331949 [PubMed - as supplied by publisher]
	An intelligent MRI-based all-in-one diagnostic strategy for axillary lymph node status in breast cancer. Nat Commun Zhang X, Qiu Y, Su Y, Yao Q, Li H, Zheng S, Tang X, Su W, Yusufu R, Huang Y, Chen X, Gao C, Ding M, Yang S, Zeng Y, Li Y, Zhao J, Peng Y, Liu Z, Chen R, Yang Z, Xiong L, Mao N, Liu Z, Shen J. PMID: 42331837 [PubMed - as supplied by publisher]
	Factors influencing women's preferences and decision making regarding the extent of axillary surgery in breast cancer: A systematic review. Eur J Surg Oncol Cooke R, Baxter P, Wyld L, Morgan J. PMID: 42330708 [PubMed - as supplied by publisher]
	Primary results from EL1SSAR, a prospective phase IIIb study of first-line atezolizumab plus nab-paclitaxel therapy for patients with PD-L1-positive advanced triple-negative breast cancer. Breast Gianni L, Delaloge S, Ciruelos E, Trédan O, Castañeda C, Abreu MH, Paris I, Colleoni M, Scandurra G, Kwiatkowski M, Antone N, Gregorc V, Tagliaferri P, Bor, Blancas I, Raimondo M, Alfie M, Arce-Salinas C, Madeira PS, Lin YG, Ye C, Koli K, Mouta J, Martin M. PMID: 42330688 [PubMed - as supplied by publisher]
	Feasibility of Ultrasound-Guided Vacuum-Assisted Breast Biopsy for Breast Nodules in Patients with Retroglandular Breast Implants. J Vis Exp Meng Z, Wang S, Sun P, Hu X, Zhao J. PMID: 42329812 [PubMed - indexed for MEDLINE]
	Second and subsequent lines of systemic therapy in endometrial cancer - a real-life clinical experience. Klin Onkol Markéta B, Michaela K, Petra O, Jitka H, Lucie E, Michal F, Martina T, Lubo, Vít W. PMID: 42329756 [PubMed - indexed for MEDLINE]
	Is endothelial dysfunction induced by aromatase inhibitors reversible after treatment? Breast Cancer Res Treat Dabour MS, Shaaban A, Duprez DA, Zordoky BN, Blaes AH. PMID: 42329476 [PubMed - indexed for MEDLINE]
	Receptor discordance between primary tumors and nodal metastases and correlation with the 21-gene recurrence score in early-stage, estrogen receptor-positive, node-positive breast cancer. Breast Cancer Res Treat Zheng S, Sullivan P, Vadehra K, Kim J, Levee A, Callahan R, Teshome M, Tseng CH, Bardia A, Kapoor NS. PMID: 42329472 [PubMed - indexed for MEDLINE]
	Efficacy and toxicity of neoadjuvant chemotherapy versus chemo-immunotherapy in triple-negative breast cancer patients with and without germline BRCA mutations. Breast Cancer Res Treat Etan T, Cohen L, Bar Y, Leshem Y, Lerner S, Stepansky I, Shiran I, Sonnenblick A, Shachar SS. PMID: 42329463 [PubMed - indexed for MEDLINE]
	Clinical implications of discordance in HER2 reassessment from HercepTest to 4B5 in metastatic breast cancer. Breast Cancer Res Treat Yamaguchi Y, Hoshino M, Shimoi T, Tamura H, Natori Y, Saiki T, Yamanaka T, Kitadai R, Saito A, Kita S, Maejima A, Kojima Y, Sudo K, Maeshima AM, Murata T, Takayama S, Naoi Y, Yonemori K, Yoshida M. PMID: 42329461 [PubMed - indexed for MEDLINE]
	Surgeon interpretation of margin status utilizing intraoperative 3D tomosynthesis during breast-conserving surgery. Breast Cancer Res Treat Leonard LD, Cohen E, Perry R, Sun J, Ehlers R, Refinetti A, Johnson HM, Akay C, Colen JS, DeSnyder S, Fallahian F, Hwang R, Hunt KK, Wu Y, Tamirisa N. PMID: 42329454 [PubMed - indexed for MEDLINE]
	Sacituzumab Tirumotecan Across Gynecologic Malignancies: One Target, Multiple Diseases. Curr Oncol Rep Sofianidi AA, Panagodimou E, Kalampokas E, Georgakopoulos I, Zagouri F. PMID: 42329328 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 330535

Page 1 of 16527



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy